Core Viewpoint - The announcement details a change in the equity structure of Shanghai Aladdin Biochemical Technology Co., Ltd., primarily due to the dissolution and liquidation of its employee stock ownership platform, Shanghai Jingzhen Cultural and Artistic Development Center (Limited Partnership), which will lead to a non-trading transfer of shares among partners without affecting the company's control or governance structure [2][9][10]. Group 1: Equity Change Details - The equity change is initiated by the dissolution of the employee stock ownership platform, which will transfer shares to its partners through a non-trading transfer [2][9]. - After the completion of this non-trading transfer, the platform will no longer hold any shares in the company, and the overall shareholding of the controlling shareholder and actual controller will decrease [3][5]. - The platform currently holds 7,381,190 shares, accounting for 2.22% of the company's total equity [9]. Group 2: Shareholding Structure - The controlling shareholder, Zhao Liping, will see an increase in her shareholding after the transfer, while the platform's shareholding will be eliminated [3][10]. - The announcement specifies that the non-trading transfer will not lead to any change in the company's control or affect its governance structure and daily operations [2][9]. Group 3: Regulatory Compliance - The company will comply with the relevant regulations, including the disclosure of a simplified equity change report and the necessary procedures for the non-trading transfer [6][10]. - The transfer process will be handled by the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [10][19].
上海阿拉丁生化科技股份有限公司关于控股股东、实际控制人权益变动的提示性公告